Intermittent Fasting: What the Research Has Measured

This content is educational. It describes what research has measured about intermittent fasting protocols. It is not dietary advice. Fasting is inappropriate for some populations including pregnant or breastfeeding women, people with history of disordered eating, people managing diabetes on insulin, children and adolescents, and people significantly underweight. Consult a healthcare professional before starting any fasting regimen.

Why this matters

Intermittent fasting has moved from research lab to consumer mainstream over the past decade. Time-restricted eating (16:8), alternate-day fasting, and 5:2 protocols are widely marketed, often with confident health claims. The research base has expanded substantially in parallel — there are now several hundred controlled human trials, multiple meta-analyses, and ongoing investigations.

The honest summary of what the research shows is more measured than most consumer content suggests. Some claims are well-supported, others are not, and the safety profile depends heavily on individual context. This page describes what the published trials have measured.

What "intermittent fasting" actually means

The umbrella term covers several distinct protocols:

Each has different mechanisms, different evidence, and different risk profiles. Treating "intermittent fasting" as a single intervention obscures meaningful differences.

The core question: does fasting do something beyond calorie restriction?

The most-contested research question is whether intermittent fasting produces effects beyond what equivalent caloric restriction would produce, or whether the benefits are simply caloric.

Several mechanisms have been proposed for fasting-specific effects:

• Metabolic switching — depletion of liver glycogen, shift toward fat oxidation and ketone bodies
• Autophagy induction — cellular recycling processes upregulated during extended fasting
• mTOR suppression — nutrient-sensing pathway dampening
• Sirtuin activation — longevity-associated proteins
• Circadian alignment — eating windows may align metabolism with circadian rhythm

The mechanistic evidence in animal models for these pathways is strong. The translation to human-relevant clinical outcomes is less clear and is the focus of much current research.

What controlled trials have measured

Weight and body composition

The most-replicated finding: intermittent fasting produces weight loss similar to continuous caloric restriction when total calories are matched.

A 2017 meta-analysis pooling 28 trials reported that intermittent fasting and continuous restriction produced equivalent weight loss over comparable periods, with neither approach showing a clear superiority [Cioffi et al. 2018].

A 2020 landmark trial randomised participants to 16:8 time-restricted eating vs. ad libitum eating for 12 weeks. The TRE group lost a modest amount of weight (~1.7% of body weight) — comparable to other modest interventions, not transformative [Lowe et al. 2020].

The honest summary: fasting protocols help most people eat less, and the resulting calorie deficit produces weight loss. The protocols are effective in proportion to the calorie deficit they create, not because of fasting-specific mechanisms.

Insulin sensitivity and glucose regulation

Several trials have measured improvements in insulin sensitivity and glucose regulation with intermittent fasting.

A 2018 trial in pre-diabetic men reported that 6-hour eating window TRE improved insulin sensitivity and beta-cell function even when participants didn't lose weight [Sutton et al. 2018]. This is one of the strongest results suggesting fasting-specific (non-calorie-mediated) effects.

Subsequent trials have produced mixed results. The Sutton finding has been partially but not fully replicated. The mechanism likely involves both circadian alignment of eating with light exposure and the metabolic switching effects of extended fasting [Hutchison et al. 2019].

Cardiometabolic markers

Cholesterol, triglycerides, blood pressure, and inflammatory markers have been measured across many fasting trials. The pattern: modest improvements consistent with the weight loss and dietary quality changes that often accompany fasting protocols. Whether fasting-specific effects beyond these are present is less clear.

Cognitive function

Some animal studies have suggested fasting may improve cognitive function and protect against neurodegeneration. Human trial data is limited and mixed. The translation from rodent models to human cognition is not yet well-established.

Longevity outcomes

Despite the longevity association in marketing, no human trial has measured intermittent fasting against mortality outcomes. The animal evidence is suggestive but the relationship between calorie restriction (the parent intervention) and lifespan extension in humans is still being established (see our caloric restriction piece).

The fasting-mimicking diet (Walter Longo)

Walter Longo's research group at USC has developed and tested fasting-mimicking diets — 5-day very-low-calorie protocols designed to trigger the autophagy and stress-response benefits of fasting without sustained restriction.

A 2017 trial in healthy adults reported that three cycles of a 5-day fasting-mimicking diet over 3 months produced reductions in body weight, fasting glucose, IGF-1, cholesterol, and blood pressure, with effects persisting after participants resumed normal eating [Wei et al. 2017].

Subsequent trials have explored fasting-mimicking diets in cancer therapy adjuncts, multiple sclerosis, and aging biomarkers. Results are encouraging but the broader human evidence base is still smaller than the animal data.

For most healthy adults, fasting-mimicking diets remain a more experimental intervention with promising early evidence rather than a well-established practice.

Adherence and real-world outcomes

A consistent finding across trials: adherence to fasting protocols is variable, and the protocols that work in controlled studies may not work as well in real-world settings.

Several patterns:

• TRE (16:8) adherence is typically the highest — most people find skipping breakfast or dinner achievable
• ADF and 5:2 adherence is lower — the dramatic calorie differences between days are harder to sustain
• Multi-day fasting adherence is variable — works for some, intolerable for others
• Initial weight loss is similar across protocols — long-term maintenance is the harder question

A 2024 meta-analysis pooling longer-term trials (>6 months) reported that the modest weight loss benefit of intermittent fasting often diminished over time as adherence declined and metabolic adaptation occurred [Patikorn et al. 2021].

The honest framing: fasting protocols are tools that work for some people in some contexts. They are not magic, and they require sustained behavioural change.

Safety considerations

The marketing around intermittent fasting often understates real safety concerns.

Where fasting is contraindicated

• Pregnancy and breastfeeding — caloric restriction is generally contraindicated
• Children and adolescents — interferes with growth; not appropriate
• History of eating disorders — fasting protocols can trigger relapse
• Underweight adults (BMI <20) — restrictive eating is inappropriate
• Type 1 diabetes — risk of dangerous blood sugar changes
• Type 2 diabetes on insulin — requires careful medical management of dosing
• Adrenal insufficiency — fasting may exacerbate cortisol-related issues

Where caution is warranted

• Older adults — sarcopenia risk; muscle loss can outpace fat loss
• Active athletes — protein timing requirements may conflict with fasting windows
• People on medications requiring food — many drugs have specific food-related dosing requirements
• Shift workers — circadian disruption may compound metabolic effects

Common side effects

Most fasting protocols produce some initial side effects:

• Headache (often related to caffeine timing or hydration)
• Hunger (typically diminishes after 2-3 weeks for many people)
• Irritability or "hanger"
• Reduced cold tolerance
• Difficulty maintaining socially normal eating patterns
• Difficulty maintaining exercise performance during fasted training

These usually diminish with adaptation but may persist for some people. Persistent severe effects warrant reconsidering the protocol.

Disordered eating risk

Restrictive eating patterns can precipitate or maintain eating disorders in vulnerable individuals. This is significantly underrepresented in consumer fasting content. People with subclinical disordered eating patterns may interpret fasting research as validation for harmful behaviours.

If thinking about food or food restriction is causing distress, fasting protocols are likely inappropriate regardless of any potential health benefits.

What this means for consumers

The research on intermittent fasting supports several relatively modest claims:

• Time-restricted eating and other fasting protocols can produce weight loss similar to caloric restriction
• Metabolic improvements (insulin sensitivity, glucose regulation) have been measured, sometimes beyond what would be expected from weight loss alone
• Fasting-mimicking diets show particularly interesting biomarker effects
• Adherence varies substantially across protocols and individuals
• Long-term outcomes (years) are not yet well-established

The research does not strongly support:

• Specific "longevity benefits" beyond caloric restriction
• Dramatic transformations beyond what equivalent dietary patterns would produce
• Universal applicability across populations
• Safety in populations where fasting is contraindicated

For readers considering intermittent fasting: TRE in the 12-14 hour overnight window (essentially a moderate eating curfew) is the most-supported by both efficacy data and safety profile. More aggressive protocols (16:8, ADF, multi-day) have evidence but should be approached with consideration of individual context and ideally with healthcare professional input.

Related Proco pages

• Caloric restriction research: 90 years of studies
• Ultra-processed food research
• Why nutrition research is uniquely hard
• The Mediterranean diet research

Sources

Proco provides educational, research-based information. This page describes what intermittent fasting research has measured. It is not dietary advice. Fasting is inappropriate for many people. If you are pregnant, breastfeeding, manage diabetes or another chronic condition, have a history of disordered eating, or are caring for children — consult a qualified healthcare professional before considering any fasting protocol.

Schema (for implementation)

{
  "@context": "https://schema.org",
  "@type": "Article",
  "headline": "Intermittent Fasting: What the Research Has Measured",
  "description": "Intermittent fasting protocols include time-restricted eating, alternate-day fasting, and 5:2. Trials have measured weight, metabolic outcomes, and adherence. This page describes what the research actually shows.",
  "datePublished": "2026-06-01",
  "dateModified": "2026-05-31",
  "author": {"@type": "Organization", "name": "Proco"},
  "publisher": {"@type": "Organization", "name": "Proco", "url": "https://procohq.com"},
  "about": {"@type": "Thing", "name": "Intermittent fasting research"}
}